Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RDNT
stocks logo

RDNT

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
515.64M
+8.08%
0.205
-6.82%
522.35M
+10.81%
-0.063
-81.91%
546.02M
+9.59%
0.237
-23.65%
Estimates Revision
The market is revising No Change the revenue expectations for RadNet, Inc. (RDNT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 13.54%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+13.54%
In Past 3 Month
Wall Street analysts forecast RDNT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RDNT is 79.25 USD with a low forecast of 71.00 USD and a high forecast of 92.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast RDNT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RDNT is 79.25 USD with a low forecast of 71.00 USD and a high forecast of 92.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 81.080
sliders
Low
71.00
Averages
79.25
High
92.00
Current: 81.080
sliders
Low
71.00
Averages
79.25
High
92.00
Barclays
Overweight
maintain
$79 -> $86
2025-11-13
Reason
Barclays
Price Target
$79 -> $86
2025-11-13
maintain
Overweight
Reason
Barclays raised the firm's price target on RadNet to $86 from $79 and keeps an Overweight rating on the shares following the investor day. The firm says the company's 2028 financial targets of 11%-13% revenue growth and 100-150 points of margin expansion support a mid-teens EBITDA growth outlook.
Truist
Buy
upgrade
$81 -> $90
2025-11-12
Reason
Truist
Price Target
$81 -> $90
2025-11-12
upgrade
Buy
Reason
Truist raised the firm's price target on RadNet to $90 from $81 and keeps a Buy rating on the shares. The firm is bullish on the stock following the company's upbeat Investor Day showcasing RadNet's broad capabilities and increasingly interconnected/integrated offerings, the analyst tells investors in a research note. RadNet is enviably positioned with strong demand and favorable overarching tailwinds, the firm added.
Barclays
Overweight
maintain
$60 -> $79
2025-09-03
Reason
Barclays
Price Target
$60 -> $79
2025-09-03
maintain
Overweight
Reason
Barclays raised the firm's price target on RadNet to $79 from $60 and keeps an Overweight rating on the shares following the Q2 report. The company's volume and productivity gains should build through fiscal Q1 of 2026, which creates a favorable share setup for the back half of 2025. It expects positive revisions to 2026 numbers.
Truist
Buy
maintain
$74 -> $81
2025-09-03
Reason
Truist
Price Target
$74 -> $81
2025-09-03
maintain
Buy
Reason
Truist raised the firm's price target on RadNet to $81 from $74 and keeps a Buy rating on the shares. The firm is bullish on the stock following its upbeat management meetings that highlighted robust core imaging center demand trends alongside a wide range of areas of opportunity for the company, supported by ongoing brisk investment in Digital Health, the analyst tells investors in a research note. RadNet is also well positioned to augment core trends via opportunistic M&A, Truist added.
B. Riley
NULL -> Buy
initiated
$69
2025-06-13
Reason
B. Riley
Price Target
$69
2025-06-13
initiated
NULL -> Buy
Reason
B. Riley initiated coverage of RadNet with a Buy rating and $69 price target.
B. Riley
B. Riley
Buy
initiated
$69
2025-06-13
Reason
B. Riley
B. Riley
Price Target
$69
2025-06-13
initiated
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for RadNet Inc (RDNT.O) is 124.41, compared to its 5-year average forward P/E of 80.44. For a more detailed relative valuation and DCF analysis to assess RadNet Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average PE
80.44
Current PE
124.41
Overvalued PE
111.32
Undervalued PE
49.56

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
15.68
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
19.27
Undervalued EV/EBITDA
12.09

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.51
Current PS
0.00
Overvalued PS
2.25
Undervalued PS
0.77
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 139.49% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

RDNT News & Events

Events Timeline

(ET)
2025-12-04
17:10:00
RadNet Files Automatic Mixed Securities Shelf
select
2025-12-04
17:10:00
RadNet Files to Sell Common Stock for Holders
select
2025-12-01 (ET)
2025-12-01
08:50:00
B. Riley Raises RadNet Price Target to $87 Following Investor Day
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
3.5
12-01Newsfilter
DeepHealth Launches AI-Powered Breast Suite, Boosting Detection Rates by 21%
  • Detection Rate Increase: The launch of DeepHealth's Breast Suite resulted in a 21% increase in breast cancer detection rates based on a real-world analysis involving over 579,000 women, which not only enhances diagnostic accuracy but also provides earlier intervention opportunities for patients.
  • Risk Assessment Innovation: The AI-powered risk assessment tool within the suite identifies breast cancer risk within 1-2 years with twice the accuracy of traditional questionnaire models, significantly improving early detection effectiveness and thereby enhancing patient treatment outcomes.
  • Workflow Optimization: The Breast Suite integrates a cloud-first multi-modality viewer and prioritized worklist, enabling rapid processing of high-suspicion cases within minutes, which greatly enhances radiologist efficiency and accelerates patient follow-up times.
  • Clinical Standardization: By offering consistent automated density assessments and intelligent reporting features, the suite not only improves clinical consistency but also drives the standardization of breast cancer screening, ensuring all patients receive high-quality care.
[object Object]
Preview
5.0
12-01NASDAQ.COM
DeepHealth Introduces Advanced Imaging Informatics and Clinical AI Solutions at RSNA 2025

  • DeepHealth's New Offerings: DeepHealth, a subsidiary of RadNet, has launched an expanded portfolio of imaging informatics and clinical AI solutions at the RSNA 2025 meeting, focusing on unifying clinical and operational intelligence to enhance AI adoption in imaging and population health.

  • Key Product Suites: The portfolio includes several key suites such as the Diagnostic Suite for image management, TechLive for remote imaging, and specialized suites for breast, thyroid, neuro, chest, and prostate applications, all designed to improve workflow efficiency and patient access.

  • Integration and Deployment: DeepHealth's solutions are already in use across RadNet's 407 imaging centers and other sites, with over 5,000 radiologists utilizing these innovations to enhance patient care and operational workflows.

  • Market Performance: RadNet's stock closed at $82.79 before a slight decline in after-hours trading, with a trading volume of approximately 559k shares, reflecting a stable performance over the past year.

[object Object]
Preview
3.5
11-30Globenewswire
DeepHealth Unveils AI Imaging Solutions to Enhance Diagnostic Efficiency
  • Portfolio Expansion: At RSNA 2025, DeepHealth unveiled next-generation imaging informatics and clinical AI solutions that span disease detection, assessment, and monitoring, aiming to enhance healthcare delivery through integrated clinical and operational intelligence.
  • Diagnostic Suite Innovation: The newly launched Diagnostic Suite™ accelerates radiology workflows with cloud data management and AI-powered automated reporting, successfully deployed across RadNet and other clients, significantly improving imaging management efficiency.
  • Breast Cancer Detection Improvement: The DeepHealth Breast Suite's AI applications achieved a 21% increase in breast cancer detection rates among 579,000 women, supporting over 10 million mammograms annually and facilitating earlier disease detection.
  • Intelligent Imaging Operations: The Operations Suite™ integrates scheduling, registration, and patient communication, aiming to reduce administrative burdens and optimize system coordination, with deployments at RadNet and other clients enhancing overall operational efficiency.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is RadNet Inc (RDNT) stock price today?

The current price of RDNT is 81.08 USD — it has increased 2.04 % in the last trading day.

arrow icon

What is RadNet Inc (RDNT)'s business?

RadNet, Inc. is a national provider of fixed-site diagnostic imaging services in the United States. The Company has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. It provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. It is also a provider of AI-powered breast health solutions.

arrow icon

What is the price predicton of RDNT Stock?

Wall Street analysts forecast RDNT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RDNT is 79.25 USD with a low forecast of 71.00 USD and a high forecast of 92.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is RadNet Inc (RDNT)'s revenue for the last quarter?

RadNet Inc revenue for the last quarter amounts to 522.87M USD, increased 13.39 % YoY.

arrow icon

What is RadNet Inc (RDNT)'s earnings per share (EPS) for the last quarter?

RadNet Inc. EPS for the last quarter amounts to 0.07 USD, increased 75.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for RadNet Inc (RDNT)'s fundamentals?

The market is revising No Change the revenue expectations for RadNet, Inc. (RDNT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 13.54%.
arrow icon

How many employees does RadNet Inc (RDNT). have?

RadNet Inc (RDNT) has 8546 emplpoyees as of December 05 2025.

arrow icon

What is RadNet Inc (RDNT) market cap?

Today RDNT has the market capitalization of 6.26B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free